Compass Therapeutics Insider Trades

CMPX

Track insider trading activity from Compass Therapeutics executives and directors. See which insiders are buying and selling CMPX stock.

Trades Last 12 Months

CMPX Price

All Insider Trades for Compass Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Anderman Jonathan General Counsel
Holding Value $412k 196,000 shares
Last Trade
Apr 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.8k 25,000 shares
$1.67
$2.10
Lerner Neil Chief Accounting Officer
Holding Value $835k 397,500 shares
Last Trade
Apr 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.1k 15,000 shares
$1.67
$2.10
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER
Holding Value $13.9M 6,603,336 shares
Last Trade
Feb 08, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$239k 36,687 shares
$6.52
$2.10
Ferneau Philip Director
Holding Value $189k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 90,000 shares
$5.17
$2.10
Gordon Carl L Director
Holding Value $189k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 90,000 shares
$5.17
$2.10
Gray Mary Ann Director
Holding Value $189k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 90,000 shares
$5.17
$2.10
Holding Value $189k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 90,000 shares
$5.17
$2.10
Boylan James P Director
Holding Value $189k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 90,000 shares
$5.17
$2.10
Chiniara Ellen Director
Holding Value $189k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 90,000 shares
$5.17
$2.10
Prasad Arjun Chief Commercial Officer
Holding Value $2.1M 1,000,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.17M 1,000,000 shares
$5.17
$2.10
Holding Value $1.41M 670,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.11M 795,000 shares
$5.17
$2.10
Sirard Cynthia Chief Medical Officer
Holding Value $2.1M 1,000,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.17M 1,000,000 shares
$5.17
$2.10
Holding Value $0 0 shares
Last Trade
Apr 09, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.68M 3,571,428 shares
$1.59
$2.10
Bisker Leib Vered CHIEF EXECUTIVE OFFICER
Holding Value $6.56M 3,124,426 shares
Last Trade
Feb 08, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$71.3k 49,198 shares
$1.45
$2.10
Holding Value $30.8M 14,690,178 shares
Last Trade
May 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$116k 64,700 shares
$1.79
$2.10
Kalled Susan Chief Scientific Officer
Holding Value $126k 60,000 shares
Last Trade
Feb 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 60,000 shares
$2.40
$2.10
Kaplan Brett Director
Holding Value $63k 30,000 shares
Last Trade
Feb 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72k 30,000 shares
$2.40
$2.10
Holding Value $63k 30,000 shares
Last Trade
Feb 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72k 30,000 shares
$2.40
$2.10
Sunderland Julie Director
Holding Value $5.25M 2,502,025 shares
Last Trade
Jun 19, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$2.10
Gladney Dan W President And CEO
Holding Value $0 0 shares
Last Trade
Feb 24, 2006 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$2.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up